HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan B Bressler Selected Research

Therapeutics

6/2020ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical Trials.
1/2019Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical Trial.
10/2018CHANGES IN DIABETIC RETINOPATHY SEVERITY WHEN TREATING DIABETIC MACULAR EDEMA WITH RANIBIZUMAB: DRCR.net Protocol I 5-Year Report.
1/2018Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
1/2017Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
3/2016Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment.
12/2015RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
5/2015Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment.
3/2014Comparison of time- and spectral-domain optical coherence tomography in management of diabetic macular edema.
8/2013Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan B Bressler Research Topics

Disease

33Macular Edema
01/2023 - 01/2008
28Macular Degeneration (Age-Related Maculopathy)
02/2024 - 10/2002
21Diabetic Retinopathy (Retinopathy, Diabetic)
12/2021 - 01/2008
19Choroidal Neovascularization
01/2015 - 10/2002
5Eye Diseases (Eye Disease)
09/2021 - 02/2003
5Cataract (Cataracts)
12/2015 - 11/2009
3Geographic Atrophy
02/2014 - 11/2005
3Endophthalmitis (Ophthalmia)
08/2013 - 06/2010
3Hemorrhage
09/2010 - 03/2004
2Myopia
02/2023 - 04/2003
2Retinal Vein Occlusion
12/2022 - 07/2007
2Retinal Detachment (Retinal Detachments)
06/2020 - 11/2005
2Edema (Dropsy)
11/2018 - 03/2004
2Glaucoma
05/2015 - 08/2013
2Vitreous Hemorrhage
08/2013 - 04/2005
2Disease Progression
11/2009 - 05/2006
2Histoplasmosis
04/2005 - 12/2004
2Back Pain (Backache)
02/2004 - 10/2002
1Inflammation (Inflammations)
02/2024
1Polypoidal Choroidal Vasculopathy
01/2022
1Retinal Diseases
05/2015
1Open-Angle Glaucoma (Glaucoma, Open Angle)
05/2015
1Telangiectasis (Telangiectasia)
10/2014
1Lung Neoplasms (Lung Cancer)
02/2014
1Vision Disorders (Hemeralopia)
06/2012
1Blindness (Hysterical Blindness)
06/2012
1Epiretinal Membrane (Epiretinal Membranes)
10/2010
1Hypoxia (Hypoxemia)
10/2009
1Central Serous Chorioretinopathy
04/2009
1Microaneurysm
01/2008
1Hematoma
04/2005
1Diabetes Mellitus
03/2004
1Injection Site Reaction
02/2004

Drug/Important Bio-Agent (IBA)

19Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 10/2009
19Ranibizumab (Lucentis)FDA Link
01/2022 - 06/2010
14Verteporfin (Visudyne)FDA Link
01/2022 - 10/2002
11Retinaldehyde (Retinal)IBA
02/2023 - 03/2004
10Fluorescein (Funduscein)FDA LinkGeneric
04/2012 - 04/2003
7afliberceptIBA
02/2024 - 01/2016
5Bevacizumab (Avastin)FDA Link
02/2024 - 01/2008
5Triamcinolone (Aristocort)FDA Link
04/2016 - 07/2008
3salicylhydroxamic acid (SHAM)IBA
06/2020 - 06/2011
3Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
08/2013 - 06/2011
2VitaminsIBA
09/2021 - 06/2008
2Hemoglobins (Hemoglobin)IBA
11/2018 - 05/2006
2ZeaxanthinsIBA
02/2014 - 07/2013
2LuteinIBA
02/2014 - 07/2013
2Retinal Pigments (Pigments, Visual)IBA
11/2005 - 07/2005
21-phenyl-3,3-dimethyltriazene (PDT)IBA
08/2004 - 04/2004
1faricimabIBA
02/2024
1pegcetacoplanIBA
02/2024
1brolucizumabIBA
02/2024
1SolutionsIBA
02/2024
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2022
1APTIBA
12/2015
1ZincIBA
02/2014
1Vitamin EFDA LinkGeneric
02/2014
1CopperIBA
02/2014
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
02/2014
1beta Carotene (Betacarotene)FDA Link
02/2014
1Green OrIBA
11/2013
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
07/2013
1Endothelial Growth FactorsIBA
05/2013
1Angiogenesis InhibitorsIBA
10/2009
1amsonic acid (DAS)IBA
12/2004

Therapy/Procedure

23Therapeutics
06/2020 - 10/2002
15Photochemotherapy (Photodynamic Therapy)
01/2022 - 10/2002
15Lasers (Laser)
12/2021 - 12/2004
15Light Coagulation
06/2020 - 11/2005
6Injections
12/2022 - 06/2011
4Vitrectomy
06/2020 - 10/2010
2Retreatment
01/2016 - 03/2014
2Aftercare (After-Treatment)
01/2015 - 09/2012
1Traction
06/2020
1Intravitreal Injections
08/2013
1Glycemic Control
07/2008
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
02/2005
1Contact Lenses
03/2004
1Ambulatory Care (Outpatient Care)
02/2003